Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712-1074, United States.
Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712-1074, United States.
Toxicol Lett. 2014 Jun 5;227(2):99-112. doi: 10.1016/j.toxlet.2014.03.019. Epub 2014 Apr 2.
A typical clinical cis-diamminedichloroplatinum(II) (cisplatin) dosing regimen consists of repeated treatment cycles followed by a recovery period. While effective, this dosing structure results in a prolonged, often permanent, infertility in men. Spermatogonial stem cells (SSCs) are theoretically capable of repopulating the seminiferous tubules after exposure has ceased. We propose that an altered spermatogonial environment during recovery from the initial treatment cycle drives an increase in SSC mitotic cell activity, rendering the SSC pool increasingly susceptible to cisplatin-induced injury from subsequent cycles. To test this hypothesis, the undifferentiated spermatogonia population and niche of the adult mouse (C57/BL/6J) were examined during the recovery periods of a clinically-relevant cisplatin exposure paradigm. Histological examination revealed a disorganization of spermatogenesis correlating with the number of exposure cycles. Quantification of terminal deoxynucleotidyl transferase-mediated digoxigenin-dUTP nick end labeling (TUNEL) staining indicated an increase in apoptotic frequency following exposure. Immunohistochemical examination of Foxo1 and incorporated BrdU showed an increase in the undifferentiated spermatogonial population and mitotic activity in the recovery period in mice exposed to one cycle, but not two cycles of cisplatin. Immunohistochemical investigation of glial cell line-derived neurotrophic factor (GDNF) revealed an increase in production along the basal Sertoli cell membrane throughout the recovery period in all treatment groups. Taken together, these data establish that the impact of cisplatin exposure on the functional stem cell pool and niche correlates with: (1) the number of dosing cycles; (2) mitotic activity of early germ cells; and (3) alterations in the basal Sertoli cell GDNF expression levels after cisplatin-induced testicular injury.
典型的顺式二氨二氯铂(II)(顺铂)临床剂量方案包括重复治疗周期和恢复期。虽然有效,但这种剂量结构会导致男性长期甚至永久性不育。精原干细胞(SSC)理论上能够在暴露停止后重新填充生精小管。我们提出,在初始治疗周期恢复期间,生精细胞环境的改变会导致 SSC 有丝分裂细胞活性增加,从而使 SSC 池对随后周期的顺铂诱导损伤更加敏感。为了验证这一假设,我们在临床相关顺铂暴露模型的恢复期间检查了成年小鼠(C57/BL/6J)未分化精原细胞群体和小生境。组织学检查显示,生精发生的紊乱与暴露周期的数量相关。末端脱氧核苷酸转移酶介导的 digoxigenin-dUTP 缺口末端标记(TUNEL)染色的定量分析表明,暴露后凋亡频率增加。Foxo1 和掺入 BrdU 的免疫组织化学检查显示,在仅接受一个周期顺铂暴露的小鼠的恢复期间,未分化精原细胞群体和有丝分裂活性增加,但在接受两个周期顺铂暴露的小鼠中则没有。胶质细胞系衍生的神经营养因子(GDNF)的免疫组织化学研究表明,在所有治疗组的恢复期间,GDNF 的产生沿着基底支持细胞的膜增加。综上所述,这些数据表明,顺铂暴露对功能性干细胞池和小生境的影响与:(1)给药周期的数量;(2)早期生殖细胞的有丝分裂活性;(3)顺铂诱导睾丸损伤后基底支持细胞 GDNF 表达水平的改变有关。